The Japanese Journal of Antibiotics
Online ISSN : 2186-5477
Print ISSN : 0368-2781
ISSN-L : 0368-2781
EXPERIENCES WITH SULTAMICILLIN GRANULES IN PEDIATRIC PATIENTS
KOSEI IGUCHIHITOSHI KAMIYAMINORU SAKURAISHIN SHIMIZUHIDEAKI NISHIHIROSHI KAWAGUCHITAMOTSU YOSHIZUMIMASAKAZU INOUEMASAMITSU KOJIMA
Author information
JOURNAL FREE ACCESS

1988 Volume 41 Issue 12 Pages 1906-1913

Details
Abstract
Sultamicillin (SBTPC) is a combination drug of sulbactam (SBT) and ampicillin (ABPC) in an ester bonding at 1:1 ratio.
SBT, a new semisynthetic β-lactamase inhibitor restores and extends the spectrum of ABPC against resistant strains of bacteria.
SBTPC granules were administrated to 26 pediatric patients with infections, and clinical efficacies were studied in 23 patients.
The clinical efficacy rate was 95.7% and the drug was evaluated to be highly effective for the treatment of infectious diseases in the pediatric field. SBTPC was safe and well tolerated.
Content from these authors
© Japan Antibiotics Research Association
Previous article Next article
feedback
Top